Indian pharma market to touch $20 bn by 2015

The Indian pharmaceutical industry is expected to reach $ 20 billion by 2015 which will make it one of the world’s top 10 pharmaceuticals markets. According to the Associated Chambers of Commerce and Industry, India‘s clinical trials business will also reach approximately $ 1 billion by 2011, further solidifying the subcontinent as one of the world’s preferred destinations for clinical trials. With this increase an immense need has risen to address all aspects of pharmacovigilance to ensure delivering medical advances to patients, quickly and efficiently while protecting public health. In July 2010 the Ministry of Health and Family Welfare (MOHFW), India, launched a complete roadmap for pharmacovigilance in India under the Pharmacovigilance Programme of India (PvPI). The goal of this programme has been to provide safer medicines for the Indian population. There are many challenges facing the Pharmacovigilance Program of India, “The sheer number...